Results 1 to 10 of about 54,895 (202)
“Clinical outcomes of definitive interstitial/hybrid high-dose-rate and pulsed-dose-rate interventional radiotherapy (brachytherapy) for non-melanoma skin cancer: A single-center retrospective analysis” [PDF]
Clinical and Translational Radiation OncologyPurpose: To evaluate clinical outcomes and toxicity of definitive interstitial or hybrid interventional radiotherapy (IRT; brachytherapy) using high-dose-rate (HDR) or pulsed-dose-rate (PDR) techniques for non-melanoma skin cancer (NMSC) unsuitable for ...
Artur J. Chyrek +7 more
doaj +2 more sources
Clinical progress of brachytherapy for cervical cancer [PDF]
BIO Web of ConferencesCervical cancer is a prevalent malignant tumour of the female reproductive system, posing a significant threat to women's health and lives in China. Brachytherapy is a crucial component of radiotherapy for patients with locally intermediate and advanced ...
Shao Tianchi
doaj +2 more sources
Prostate International, 2023 Around 40 years have passed since a modern low-dose-rate (LDR) brachytherapy for prostate cancer was introduced. LDR brachytherapy has become one of the definitive treatment options besides radical prostatectomy (RP) and external beam radiation therapy ...
Nobumichi Tanaka
doaj +1 more source
BMC Cancer, 2022 Background Large-scale trials have shown that hypofractionated adjuvant breast radiotherapy was as effective in terms of survival and local control as conventional fractionated radiotherapy, and acute toxicity was reduced with hypofractionated ...
Marie Bruand +11 more
doaj +1 more source
Combined Interstitial and Intracavitary High-Dose Rate Brachytherapy of Cervical Cancer
Frontiers in Oncology, 2022 High-dose-rate brachytherapy by remote afterloading is now performed under three-dimensional image guidance by CT or MRI. Three-dimensional image-guided brachytherapy in cervical cancer disclosed that the traditional intracavitary brachytherapy by ...
Jun Itami +13 more
doaj +1 more source
Life, 2022 (1) Current breast-conserving therapy for breast cancer consists of a combination of many consecutive treatment modalities. The most crucial goal of postoperative treatment is to eradicate potentially relapse-forming residual cancerous cells within the ...
Adam Chicheł +6 more
doaj +1 more source
Clinical Efficacy and Openness to New Challenges of Low Dose Rate Brachytherapy for Prostate Cancer
Current Oncology, 2023 Over a century ago, low-dose-rate (LDR) brachytherapy was introduced to treat prostate cancer (PCa). Since then, it has been widely applied worldwide, including in East Asia. LDR brachytherapy has been performed in 88 institutes in Japan.
Manabu Kato +10 more
doaj +1 more source
The increasing role of functional visualization modalities for navigation of external beam radiation therapy and brachytherapy in prostate cancer [PDF]
Digital Diagnostics, 2022 Brachytherapy is successfully used in the treatment of malignant neoplasms in males and females and rare cases in children, as an independent method (with localized prostate cancer) or adjuvant with remote focal radiation therapy (with cancer of the ...
Pavel O. Rumyantsev
doaj +1 more source
Reports of Practical Oncology and RadiotherapyBACKGROUND: Basal cell carcinoma (BCC) often arises on cosmetically and functionally sensitive facial sites where standard contact brachytherapy applicators may not conform optimally. Patient-specific, 3D-printed surface applicators may improve geometric
Artur J. Chyrek +4 more
doaj +1 more source
Evaluation of brain edema formation defined by MRI after LINAC-based stereotactic radiosurgery
Radiology and Oncology, 2017 Peri-lesional edema is a serious and well-known complication of stereotactic radiosurgery (SRS). Here we evaluated edema risk after SRS and assessed its formation and resolution dynamics.
Harat Maciej +3 more
doaj +1 more source